Giant Cell Tumor Medications

Xtrenbo is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Xtrenbo is only available as a brand name drug.

Bilprevda is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Bilprevda is only available as a brand name drug.

Aukelso is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Aukelso is only available as a brand name drug.

Wyost is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Wyost is only available as a brand name drug.

Osenvelt is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Osenvelt is only available as a brand name drug.

Bomyntra is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Bomyntra is only available as a brand name drug.

DENOSUMAB prevents weakened bones caused by cancer. It may also be used to treat noncancerous bone tumors that cannot be removed by surgery. It can also be used to treat high calcium levels in the blood caused by cancer. It works by blocking a protein that causes bones to break down quickly. This slows down the release of calcium from bones, which lowers calcium levels in your blood. It also makes your bones stronger and less likely to break (fracture).

PEXIDARTINIB treats noncancerous tumors that occur in joints. It works by blocking a protein that causes tumor cells to grow and multiply.

Romvimza is part of the Kinase Inhibitors class and treats Giant Cell Tumor. Kinase inhibitors are used to treat cancers such as leukemia, breast cancer, melanoma, lung cancer, and renal cancer. They are also used to prevent organ transplant rejection. They work by stopping cancer cell growth and preventing the spread of the cells. Romvimza is only available as a brand name drug.

Jubereq is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Jubereq is only available as a brand name drug.

Oziltus is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Oziltus is only available as a brand name drug.

Xbryk is part of the RANKL Inhibitors class and treats Giant Cell Tumor, Hypercalcemia and Multiple Myeloma. RANKL inhibitors are used to treat osteoporosis, breast cancer, lung cancer, and prostate cancer. They work by preventing bone fractures and by destroying cancer cells. Xbryk is only available as a brand name drug.